India's GLP-1 anti-obesity drug market has neared Rs 1,906 crore as growth begins to moderate after a rapid surge. Physicians and industry executives say government advisories and tighter patient selection are steering the market towards more disciplined, prescription-led expansion.
At ASCO, Shubham Pant was one of the co-authors of the trial showing Daraxonrasib improved outcomes in advanced pancreatic cancers. The results showed the KRAS-targeted drug offers longer survival and better quality of life.
Apitegromab reduced muscle loss by more than half when used with tirzepatide in an early clinical trial. The findings raise hopes of protecting muscle health as GLP-1 medicines gain ground for weight loss and diabetes.
An ICMR-NIN study has linked deficiencies in vitamins D, B2, B6 and B12 with higher dementia risk among Indian adults. The findings point to nutrition and dietary diversity as possible targets for dementia prevention.
Molbio Diagnostics is validating a portable Ebola PCR test with WHO-backed partners in the DRC and Uganda. The effort aims to ease testing shortages and speed outbreak response in hard-to-reach settings.
AIIMS researchers have identified how air pollution disrupts placental pathways linked to fetal growth. The findings connect particulate exposure with inflammation, gene suppression and pregnancy complications.
Medical device makers have asked the Union health ministry to create a National Implant Registry. The push centres on patient safety, faster recalls and better long-term tracking of high-risk implants.
Serum Institute of India has joined Oxford and CEPI to speed up an experimental Bundibugyo Ebola vaccine as cases rise in the DRC and Uganda. The effort highlights the lack of any approved shot for this strain and the pressure to balance speed with limited testing.
India's crackdown on injectable cosmetic products has uncovered a wider trade in unapproved wellness drips across clinics, salons and gyms. Dermatologists say the trend is being fuelled by off-label use, weak oversight and glossy marketing despite safety concerns.
BPNI has urged the Union health ministry and FSSAI to mandate warnings that powdered infant formula is not sterile. The demand follows global recalls and sharpens concerns over contamination risks and public disclosure.
India's drug regulator has told clinics and consumers that cosmetics cannot be injected into the body. The clarification brings glutathione drips and anti-ageing shots under sharper scrutiny.
India's clinical research industry is recovering, but first-in-human studies still face caution. That gap could shape how quickly patients access new therapies and where innovation lands.
The World Health Organisation has declared the Ebola outbreak in the DRC and Uganda a global health emergency after the Bundibugyo strain spread into urban centres. The alert reflects worries over weak diagnostics, no approved vaccine and the risk of missed cross-border transmission.
A new report by the Global Preparedness Monitoring Board under the WHO and World Bank has warned that the world is becoming more vulnerable to future pandemics despite the lessons of COVID-19. It says weaker cooperation, unequal access and funding gaps are eroding global health security.
WHO has declared the Ebola outbreak in Central Africa a global health emergency after cases surfaced in the DRC and Uganda. Experts say the Bundibugyo strain, urban spread and weak diagnostics make containment harder than the MV Hondius hantavirus outbreak.
Experts say hypertension is rising across India, with younger adults increasingly affected and women often underdiagnosed. They warn that weak screening, low awareness and delayed treatment are widening cardiovascular risks.
An Indian study has found that type 2 diabetes in the country falls into distinct subtypes, with insulin-deficient forms carrying the gravest outcomes. The findings could reshape diagnosis, screening and treatment by moving care away from a one-size-fits-all approach.
Roche has launched a subcutaneous version of Tecentriq in India for eligible lung cancer patients. The approval could shorten hospital visits and sharpen the focus on convenience in cancer care.
Dr Shahid Jameel said the hantavirus response linked to the MV Hondius outbreak appears appropriate. He said the episode highlights global gaps in surveillance and the need for sustained preparedness.
Health agencies are tracing passengers and contacts linked to the MV Hondius hantavirus outbreak. The spread of Andes virus beyond the ship has sharpened questions about how it may transmit.
